The BioCanRx network is changing the face of cancer treatment

 

BioCanRx’s vision is to cure patients and enhance the quality of life of those living with cancer. We will do this by supporting world-class research in the area of immune oncology, and by accelerating to the clinic the most promising cancer immunotherapies designed to save lives and enable a better quality of life. Through an innovative, collaborative funding process BioCanRx is becoming a world-leader in the translation, manufacture and adoption of leading edge cancer immunotherapy treatments for the benefit of cancer patients.

 

 

for-resesarchers-1
for-resesarchers-1
for-resesarchers-1
for-resesarchers-1

 

 

 


Diving Deep into the Abdominal Cavity

 

Dr. Rebecca Auer holds a Catalyst Grant from BioCanRx to test the use of immunotherapy to treat peritoneal carcinomatosis. Her work on this project is intended to get the evidence needed to proceed to clinical trials and, she says, it’s looking promising.

 

Learn more →


John Bell Wins Inaugural ESGCT Public and Patient Engagement Award

 

BioCanRx is pleased to announce that Scientific Director Dr. John Bell has won the the inaugural European Society for Gene and Cell Therapy (ESGCT) Public and Patient Engagement Award.

 

Learn more →


BioCanRx Cycle II LOI Call

 

BioCanRx recently announced a Call for Letters of Intent. Selected Letters of Intent will be featured in the Scientific Program of our Cycle II application to the federal government’s Networks of Centres of Excellence (NCE) Program. The deadline for applications is May 1st, 2019.

 

Learn more →

 

 

Summit for Cancer Immunotherapy

VICTORIA, B.C.
summitforcancer
Join the BioCanRx Network at the 4th annual Summit for Cancer Immunotherapy (Summit4CI) taking place in Victoria!

October 20-23, 2019

Fairmont Empress Hotel

Learn More Sponsorship Opportunities
Learning Institute Community Dissemination Report 2018

The participants of the 2018 BioCanRx-Cancer Stakeholder Alliance Learning Institute wish to share their Community Dissemination Report with the oncology patient and researcher community, BioCanRx, the Cancer Stakeholder Alliance, and the general public.

Click here for the full report
For the latest BioCanRx news and network activities:

Subscribe to our newsletter and email updates Subscribe
Follow us on Twitter
Like us on Facebook
Follow us on Instagram Follow
Subscribe to us on Youtube  Subscribe
Follow us on LinkedIn Follow

 

Our Network Members